Alnylam Pharmaceuticals
ALNY
#544
Rank
โ‚ฌ36.48 B
Marketcap
275,13ย โ‚ฌ
Share price
-3.29%
Change (1 day)
10.93%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company